26.88000 EUR
1.355
5.31%
Last update Dec 12, 8:11 AM CET
Main market
Day range
26.88000
26.88000
Previous close
25.52500
Open
26.88000
Access this stock data via API
Subscribe
TG Therapeutics, Inc.
26.88
1.36
5.31%

Statistics

Valuation metrics
Market cap
0
Enterprise value
62.88M
Trailing P/E (ttm)
163.94
Forward P/E
PEG ratio
Price/Sales (ttm)
0
Price/Book (mrq)
Enterprise Value/Revenue
0.22
Enterprise Value/EBITDA
1.48
Overview
Shares outstanding
155.21M
Float
Shares short
% Held by insiders
% Held by institutions
Average volume (10 days)
0
Average volume (90 days)
0
Price summary
52-Week low
22.43
52-Week high
39.43
52-Week change
-14.72 -65.6%
Beta
50-Day moving average
28.12
200-Day moving average
30.09
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Sep 30, 2025
Profitability
Profit margin
88.30%
Operating margin
15.08%
Operational effectiveness
Return on assets
4.05%
Return on equity
10.52%
Income statement
Revenue (ttm)
280.23M
Revenue per share (ttm)
2.26
Quarterly revenue growth (yoy)
14.57%
Gross profit (ttm)
247.45M
EBITDA
98.16M
Net income to common (ttm)
19.92M
Diluted EPS (ttm)
0.15
Quarterly earnings growth (yoy)
89.95%
Balance sheet
Total cash (mrq)
0
Total cash per share (mrq)
Total debt (mrq)
216.11M
Total Debt/Equity (mrq)
0.42
Current ratio (mrq)
382.48%
Book value per share (mrq)
Cash flow
Cash flow statement
-52.58M
Levered free cash flow (LFCF)
330.32M
Access /statistics data via our API — starting from the Pro plan.
Main market

Exchange is currently active.
Closing in 10 hours 3 minutes

09:56
00:00
08:00
20:00
23:59

Trading Hours (Monday - Friday):

Main market
08:00 - 20:00
All times are displayed in the Europe/Berlin timezone (CET, UTC+01:00).